Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer (Q34733910)

4 August 2017

1 reference

title

Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer (English)

1 reference

4 August 2017

1 reference

Köberle D

1

1 reference

PubMed ID

12113022

4 August 2017

Thürlimann B

series ordinal

2

1 reference

PubMed ID

12113022

4 August 2017

language of work or name

1 reference

1 August 2001

1 reference

Expert Review of Anticancer Therapy

4 August 2017

1 reference

4 August 2017

1

1 reference

4 August 2017

2

1 reference

4 August 2017

169-176

1 reference

Aromatase inhibitors in relation to other forms of endocrine therapy for breast cancer

4 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.169

The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.169

Exemestane: a review of its use in postmenopausal women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.169

Letrozole. A review of its use in postmenopausal women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.169

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.169

21 January 2018

Identifiers

DOI

10.1586/14737140.1.2.169

1 reference

4 August 2017

1 reference

PubMed ID

12113022